- Home
- SWX vs IMNM Comparison
SWX vs IMNM Comparison
Compare SWX & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWX
- IMNM
- Stock Information
- Founded
- SWX 1931
- IMNM 2006
- Country
- SWX United States
- IMNM United States
- Employees
- SWX N/A
- IMNM N/A
- Industry
- SWX Oil & Gas Production
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- SWX Utilities
- IMNM Health Care
- Exchange
- SWX Nasdaq
- IMNM Nasdaq
- Market Cap
- SWX N/A
- IMNM 747.7M
- IPO Year
- SWX N/A
- IMNM 2020
- Fundamental
- Price
- SWX $73.30
- IMNM $12.27
- Analyst Decision
- SWX Hold
- IMNM Strong Buy
- Analyst Count
- SWX 3
- IMNM 4
- Target Price
- SWX $73.67
- IMNM $28.75
- AVG Volume (30 Days)
- SWX 301.9K
- IMNM 817.9K
- Earning Date
- SWX 11-06-2024
- IMNM 11-07-2024
- Dividend Yield
- SWX 3.35%
- IMNM N/A
- EPS Growth
- SWX N/A
- IMNM N/A
- EPS
- SWX 2.53
- IMNM N/A
- Revenue
- SWX $5,300,147,000.00
- IMNM $10,784,000.00
- Revenue This Year
- SWX N/A
- IMNM N/A
- Revenue Next Year
- SWX $0.27
- IMNM N/A
- P/E Ratio
- SWX $29.18
- IMNM N/A
- Revenue Growth
- SWX N/A
- IMNM 62.73
- 52 Week Low
- SWX $56.17
- IMNM $6.93
- 52 Week High
- SWX $78.47
- IMNM $30.96
- Technical
- Relative Strength Index (RSI)
- SWX 54.39
- IMNM 37.57
- Support Level
- SWX $72.66
- IMNM $12.24
- Resistance Level
- SWX $75.28
- IMNM $13.40
- Average True Range (ATR)
- SWX 1.15
- IMNM 0.79
- MACD
- SWX -0.04
- IMNM -0.22
- Stochastic Oscillator
- SWX 45.42
- IMNM 13.30
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.